Cora Best, PhD, MHS, RDN (she/her/hers)

Assistant Professor
University of Florida
Gainesville, Florida, United States

Cora Best is an Assistant Professor in the Food Science and Human Nutrition Department at the University of Florida. Her lab group is focused on advancing kidney and bone health through nutrition and elevating the role of nutrition in patient care. She currently serves as the Dennis M. Bier Early Career Editor for the American Journal of Clinical Nutrition and the Chair of the ASN Medical Nutrition Council.

Presentation(s):

• Energy and Macronutrient Metabolism, Medical Nutrition Council, and Obesity Joint GEM Forum: Highlighting the Unique Role of Hormone-Based Obesity Medications Within the Weight Loss and Weight Management Landscape

  Monday, July 1, 2024
  12:00 PM – 1:30 PM CT

  Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.

• Introductions - Energy and Macronutrient Metabolism, Medical Nutrition Council, and Obesity Joint GEM Forum: Highlighting the Unique Role of Hormone-Based Obesity Medications Within the Weight Loss and Weight Management Landscape

  Monday, July 1, 2024
  12:00 PM – 12:04 PM CT

  Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.

• Questions and Answers - Energy and Macronutrient Metabolism, Medical Nutrition Council, and Obesity Joint GEM Forum: Highlighting the Unique Role of Hormone-Based Obesity Medications Within the Weight Loss and Weight Management Landscape

  Monday, July 1, 2024
  12:54 PM – 1:06 PM CT

  Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.

• Medical Nutrition Council Updates and Awards

  Monday, July 1, 2024
  1:06 PM – 1:14 PM CT

  Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.

• Effects of Whole Foods and Oral Nutrition Supplements on Surrogate and Clinical Outcomes (Oral 26)

  Monday, July 1, 2024
  2:30 PM – 3:30 PM CT

  Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.